DIMENSIONAL FUND ADVISORS LP
Position in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 354204
AUSTIN, TX
Position in CPRX
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$84,917,266
+$14,983,698 QoQ
Shares Held
3,429,615
+14.5% QoQ
Ownership
2.80%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 87%
Shared 10%
None 3%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. CPRX ranks #14 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in CPRX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $84,917,266 | 3,429,615 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $69,933,568 | 2,996,297 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $48,425,926 | 2,458,169 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $41,393,203 | 1,907,521 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $53,044,981 | 2,187,422 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $62,881,976 | 3,013,032 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $60,013,522 | 3,018,789 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $46,481,708 | 3,000,756 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $43,638,251 | 2,737,657 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $43,736,205 | 2,601,797 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $29,924,924 | 2,559,874 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $33,229,188 | 2,472,410 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $39,369,339 | 2,374,508 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $42,941,910 | 2,308,705 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $27,501,963 | 2,143,567 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $15,720,960 | 2,242,648 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $17,784,155 | 2,145,254 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $12,887,155 | 1,903,568 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $9,296,062 | 1,753,974 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $8,400,410 | 1,460,941 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $5,469,612 | 1,186,467 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,290,441 | 685,761 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $2,041,084 | 687,234 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,967,102 | 642,230 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,103,493 | 546,362 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||